MRE11 as a prognostic biomarker for PARP‐inhibitor therapeutic response and MRN complex therapy, MRE11 in DNA repair and autophagy in cancer therapy, inhibition of adeno‐associated virus by MRN complex. The gene discussed is PARP1; the disease is cancer.